Clinical trial

Opposing Step-by-step Insulin Reinforcement to Intensified Strategy

NCT00174642

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-12-01

PhasePHASE3

Study timeline

Study start (unknown)2004-12-01Date precision: month

Registry last updated2009-09-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Insulin GlargineDRUG · verified · RxNorm: insulin glargine

Insulin GlulisineDRUG · verified · RxNorm: insulin glulisine, human

MetforminDRUG · verified · RxNorm: metformin

insulin secretagogueDRUG

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

SeoulSouth Korea1 BarcelonaSpain1 ParisFrance1 BerlinGermany1 MilanItaly1 TaipeiTaiwan1 MoscowRussia1 WarsawPoland1 BudapestHungary1 BrusselsBelgium1 IstanbulTurkey (Türkiye)1 StockholmSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00174642 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.